The management of hormone-relapsed prostate cancer

被引：13

作者：

Clarke, NW

机构：

[1] Christie Hosp NHS Trust, Dept Surg, Manchester M20 4BX, Lancs, England

[2] Salford Royal Hosp NHS Trust, Manchester, Lancs, England

来源：

BJU INTERNATIONAL | 2003年 / 92卷 / 08期

关键词：

SPINAL-CORD COMPRESSION; QUALITY-OF-LIFE; METASTATIC BONE-DISEASE; URETERAL OBSTRUCTION; DOUBLE-BLIND; CYTOTOXIC CHEMOTHERAPY; CONTROLLED-TRIAL; ORAL CLODRONATE; CARCINOMA; PALLIATION;

D O I：

10.1046/j.1464-410X.2003.04494.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

It is important that although HRPC is incurable it is not untreatable. The clinical management embraces many interventional and supportive therapies, and for optimal treatment a multidisciplinary approach is ultimately the best for the patient. In all of this it is vital that the care is patient-centred, and that the pastoral and psychological needs of the individual are appropriately addressed in the course of managing the physical needs of men with this disease.

引用

页码：860 / 868

页数：9

共 87 条

[1]

AHMANN FR, 2001, P AN M AM SOC CLIN, V30, P692

[2] Erythropoetin in urologic oncology [J].